Literature DB >> 18174475

Risk factor associations with the presence of a lipid core in carotid plaque of asymptomatic individuals using high-resolution MRI: the multi-ethnic study of atherosclerosis (MESA).

Bruce A Wasserman1, A Richey Sharrett, Shenghan Lai, Antoinette S Gomes, Mary Cushman, Aaron R Folsom, Diane E Bild, Richard A Kronmal, Shantanu Sinha, David A Bluemke.   

Abstract

BACKGROUND AND
PURPOSE: Atheroma vulnerability to rupture is increased in the presence of a large lipid core. Factors associated with a lipid core in the general population have not been studied.
METHODS: The Multi-Ethnic Study of Atherosclerosis (MESA) is a multicenter cohort study of individuals free of clinical cardiovascular disease designed to include a high proportion of ethnic minorities. We selected MESA participants from the top 15th percentile of maximum carotid intima media thickness by ultrasound and acquired high-resolution black blood MRI images through their carotid plaque before and after the intravenous administration of gadodiamide (0.1 mmol/kg). Lumen and outer wall contours were defined using semiautomated analysis software. We analyzed only plaques with a maximum thickness >or=1.5 mm by MRI (n=214) and assessed cross-sectional risk factor associations with lipid core presence by multivariable logistic regression.
RESULTS: A lipid core was present in 151 (71%) of the plaques. After controlling for age, ethnicity, sex, maximum arterial wall thickness, hypertension, cigarette smoking, diabetes, and C-reactive protein, compared with participants in the lowest tertile of total plasma cholesterol, the ORs of having a lipid core for participants in the middle and highest tertiles were 2.76 (95% CI: 1.01 to 7.51) and 4.63 (95% CI: 1.56 to 13.75), respectively. None of the other risk factors was associated with lipid core.
CONCLUSIONS: In persons with thickened carotid walls, plasma total cholesterol, but not other established coronary heart disease risk factors, is strongly associated with lipid core presence by MRI. High total cholesterol may be associated with rupture proneness of atherosclerotic lesions in the general population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18174475     DOI: 10.1161/STROKEAHA.107.498634

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  52 in total

1.  Carotid artery atherosclerosis: effect of intensive lipid therapy on the vasa vasorum--evaluation by using dynamic contrast-enhanced MR imaging.

Authors:  Li Dong; Williams S Kerwin; Huijun Chen; Baocheng Chu; Hunter R Underhill; Moni Blazej Neradilek; Thomas S Hatsukami; Chun Yuan; Xue-Qiao Zhao
Journal:  Radiology       Date:  2011-04-14       Impact factor: 11.105

2.  Comparison of carotid plaque burden among healthy middle-aged men living in the US, Japan, and South Korea.

Authors:  Abhishek Vishnu; Jina Choo; Aya Kadota; Emma J M Barinas-Mitchell; Akira Fujiyoshi; Dorothy Leann Long; Takashi Hisamatsu; Vasudha Ahuja; Yasuyuki Nakamura; Rhobert W Evans; Katsuyuki Miura; Kamal H Masaki; Chol Shin; Hirotsugu Ueshima; Akira Sekikawa
Journal:  Int J Cardiol       Date:  2018-09-01       Impact factor: 4.164

3.  Association of risk factors for atherosclerosis, including high-sensitivity C-reactive protein, with carotid intima-media thickness, plaque score, and pulse wave velocity in a male population.

Authors:  Satoko Ojima; Takuro Kubozono; Shin Kawasoe; Takeko Kawabata; Masaaki Miyata; Hironori Miyahara; Shigeho Maenohara; Mitsuru Ohishi
Journal:  Hypertens Res       Date:  2020-01-24       Impact factor: 3.872

4.  The time has come for clinical cardiovascular trials with plaque characterization as an endpoint.

Authors:  Zahi A Fayad; Venkatesh Mani; Valentin Fuster
Journal:  Eur Heart J       Date:  2011-08-28       Impact factor: 29.983

5.  Semiautomated carotid artery plaque composition: are intraplaque CT imaging features associated with cardiovascular risk factors?

Authors:  John C Benson; Giuseppe Lanzino; Valentina Nardi; Luis Savastano; Amir Lerman; Waleed Brinjikji
Journal:  Neuroradiology       Date:  2021-02-05       Impact factor: 2.804

6.  HDL efflux capacity, HDL particle size, and high-risk carotid atherosclerosis in a cohort of asymptomatic older adults: the Chicago Healthy Aging Study.

Authors:  R Kannan Mutharasan; C Shad Thaxton; Jarett Berry; Martha L Daviglus; Chun Yuan; Jie Sun; Colby Ayers; Donald M Lloyd-Jones; John T Wilkins
Journal:  J Lipid Res       Date:  2017-01-03       Impact factor: 5.922

7.  Association of parity with carotid diameter and distensibility: multi-ethnic study of atherosclerosis.

Authors:  Dhananjay Vaidya; Wendy L Bennett; Christopher T Sibley; Joseph F Polak; David M Herrington; Pamela Ouyang
Journal:  Hypertension       Date:  2014-08       Impact factor: 10.190

8.  Carotid artery plaque morphology and composition in relation to incident cardiovascular events: the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Anna E H Zavodni; Bruce A Wasserman; Robyn L McClelland; Antoinette S Gomes; Aaron R Folsom; Joseph F Polak; João A C Lima; David A Bluemke
Journal:  Radiology       Date:  2014-03-04       Impact factor: 11.105

9.  Tyrosine polyethylene glycol (PEG)-micelle magnetic resonance contrast agent for the detection of lipid rich areas in atherosclerotic plaque.

Authors:  Anne Beilvert; David P Cormode; Frédéric Chaubet; Karen C Briley-Saebo; Venkatesh Mani; Willem J M Mulder; Esad Vucic; Jean-François Toussaint; Didier Letourneur; Zahi A Fayad
Journal:  Magn Reson Med       Date:  2009-11       Impact factor: 4.668

10.  Cardiovascular magnetic resonance parameters of atherosclerotic plaque burden improve discrimination of prior major adverse cardiovascular events.

Authors:  Venkatesh Mani; Paul Muntner; Samuel S Gidding; Silvia H Aguiar; Hamza El Aidi; Karen B Weinshelbaum; Hiroaki Taniguchi; Rob van der Geest; Johan H C Reiber; Sameer Bansilal; Michael Farkouh; Valentin Fuster; John E Postley; Mark Woodward; Zahi A Fayad
Journal:  J Cardiovasc Magn Reson       Date:  2009-04-24       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.